Sinopharm unit gets approval for clinical trials of mRNA COVID vaccine

Sinopharm’s biotech unit has obtained regulatory approval for clinical trials of its mRNA COVID-19 vaccine against the Omicron variant, the company said on Friday.

Go and Vote: Issued in Public Interest